23 October 2017
News and Views
Links and Services
fiogf49gjkf04The most recent issue of the Journal of Gastroenterology & Hepatology investigates the use of osteoprotegerin as a novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma.
Osteoprotegerin is a member of the tumor necrosis factor receptor superfamily of protei
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors